Evidence map›Paper›PMID 34778063›Full record

ArticleFrontiers in oncology2021

Jiaojiao Deng, Shuchen Sun, Jiawei Chen, Daijun Wang, Haixia Cheng, Hong Chen, Qing Xie, Lingyang Hua, Ye Gong

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jiaojiao DengDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Shuchen SunDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Jiawei ChenDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Daijun WangDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Haixia ChengDepartment of Neuropathology, Huashan Hospital, Fudan University, Shanghai, China.
Hong ChenDepartment of Neuropathology, Huashan Hospital, Fudan University, Shanghai, China.
Qing XieDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Lingyang HuaDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Ye GongDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Fudan University · CNHuashan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdjuvant radiotherapy (RT) is one of the most commonly used treatments for

objectiveWe describe efforts to integrate clinical genomics to discover predictive biomarkers that would inform adjuvant treatment decisions in

methodsWe undertook a retrospective analysis of 37 patients with

resultsAmong the 172 HGMs from a single institution, 42 cases (37 WHO grade 2 meningiomas and five WHO grade 3 meningiomas) were identified as

conclusionOur findings suggest that

Indexed as

adjuvant radiotherapyde novohigh-grade meningiomasprognosisTERT alterations

Identifiers

PMID34778063
PMCPMC8586415
OpenAlexW3208672075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.